White House urges RSV vaccine makers to meet demand
By Susan Heavey and Ahmed Aboulenein WASHINGTON Senior Biden administration officials met with RSV vaccine makers this week
1970-01-01 08:00
US FDA approves Pfizer's maternal RSV vaccine to protect infants
By Patrick Wingrove and Bhanvi Satija The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial
1970-01-01 08:00
US CDC panel recommends Sanofi-AstraZeneca's preventive RSV therapy for babies
(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi
1970-01-01 08:00
EU health regulator backs Pfizer's RSV vaccine for infants, older adults
The European Union's health regulator on Friday backed authorization of Pfizer's vaccine for respiratory syncytial virus (RSV) for
1970-01-01 08:00
US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca's antibody therapy
1970-01-01 08:00
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSV
By Michael Erman and Raghav Mahobe (Reuters) -A panel of advisers to the U.S. Centers for Disease Control and Prevention
1970-01-01 08:00
GSK's RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong
1970-01-01 08:00
EU approves its first vaccine for common respiratory virus RSV
By Natalie Grover and Eva Mathews (Reuters) -European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV),
1970-01-01 08:00
U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc's
1970-01-01 08:00
Pfizer's maternal RSV vaccine effective at preventing severe infections in newborns, FDA says but flags potential risk of preterm birth
Pfizer's vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to the hospital with a moderate to severe infection before 6 months of age, according to a new analysis by government regulators.
1970-01-01 08:00